Evidence map›Paper›PMID 37564104›Full record

ArticleJID innovations : skin science from molecules to population health2023

Defining a Unique Gene Expression Profile in Mature and Developing Keloids.

Yuan O Zhu, Scott MacDonnell, Theodore Kaplan, Chien Liu, Yasmeen Ali, Stephanie M Rangel, Matthew F Wipperman, Madeleine Belback, Daphne S Sun, Ziyou Ren and 4 more

Open access · goldAbstract read
In one paragraph

Article in JID innovations : skin science from molecules to population health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Update on the Pathogenesis of Keloid Formation.JID innovations : skin science from molecules to population health · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Yuan O ZhuRegeneron Pharmaceutical, Tarrytown, New York, USA.
Scott MacDonnellRegeneron Pharmaceutical, Tarrytown, New York, USA.
Theodore KaplanRegeneron Pharmaceutical, Tarrytown, New York, USA.
Chien LiuRegeneron Pharmaceutical, Tarrytown, New York, USA.
Yasmeen AliDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Stephanie M RangelDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Matthew F WippermanRegeneron Pharmaceutical, Tarrytown, New York, USA.
Madeleine BelbackDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Daphne S SunRegeneron Pharmaceutical, Tarrytown, New York, USA.
Ziyou RenDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Xiaolong Alan ZhouDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Gabor HalaszRegeneron Pharmaceutical, Tarrytown, New York, USA.
Lori MortonRegeneron Pharmaceutical, Tarrytown, New York, USA.
Roopal V KunduDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Regeneron (United States) · USNorthwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Keloids are benign, fibroproliferative dermal tumors that typically form owing to abnormal wound healing. The current standard of care is generally ineffective and does not prevent recurrence. To characterize keloid scars and better understand the mechanism of their formation, we performed transcriptomic profiling of keloid biopsies from a total of 25 subjects of diverse racial and ethnic origins, 15 of whom provided a paired nonlesional sample, a longitudinal sample, or both. The transcriptomic signature of nonlesional skin biopsies from subjects with keloids resembled that of control skin at baseline but shifted to closely match that of keloid skin after dermal trauma. Peripheral keloid skin and rebiopsied surrounding normal skin both showed upregulation of epithelial-mesenchymal transition markers, extracellular matrix organization, and collagen genes. These keloid signatures strongly overlapped those from healthy wound healing studies, usually with greater perturbations, reinforcing our understanding of keloids as dysregulated and exuberant wound healing. In addition, 219 genes uniquely regulated in keloids but not in normal injured or uninjured skin were also identified. This study provides insights into mature and developing keloid signatures that can act as a basis for further validation and target identification in the search for transformative keloid treatments.

Identifiers

PMID37564104
PMCPMC10410242
OpenAlexW4377115731

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.